278 related articles for article (PubMed ID: 18413322)
1. Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors.
Heck DH; Zhao Y; Roy S; LeDoux MS; Reiter LT
Hum Mol Genet; 2008 Jul; 17(14):2181-9. PubMed ID: 18413322
[TBL] [Abstract][Full Text] [Related]
2. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
[TBL] [Abstract][Full Text] [Related]
3. Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a
Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM
Mol Neurobiol; 2021 Jun; 58(6):2543-2557. PubMed ID: 33464534
[TBL] [Abstract][Full Text] [Related]
4. Normal social seeking behavior, hypoactivity and reduced exploratory range in a mouse model of Angelman syndrome.
Allensworth M; Saha A; Reiter LT; Heck DH
BMC Genet; 2011 Jan; 12():7. PubMed ID: 21235769
[TBL] [Abstract][Full Text] [Related]
5. Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.
Huang HS; Burns AJ; Nonneman RJ; Baker LK; Riddick NV; Nikolova VD; Riday TT; Yashiro K; Philpot BD; Moy SS
Behav Brain Res; 2013 Apr; 243():79-90. PubMed ID: 23295389
[TBL] [Abstract][Full Text] [Related]
6. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
Mulherkar SA; Jana NR
Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.
Miura K; Kishino T; Li E; Webber H; Dikkes P; Holmes GL; Wagstaff J
Neurobiol Dis; 2002 Mar; 9(2):149-59. PubMed ID: 11895368
[TBL] [Abstract][Full Text] [Related]
8. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.
Albrecht U; Sutcliffe JS; Cattanach BM; Beechey CV; Armstrong D; Eichele G; Beaudet AL
Nat Genet; 1997 Sep; 17(1):75-8. PubMed ID: 9288101
[TBL] [Abstract][Full Text] [Related]
9. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
Mardirossian S; Rampon C; Salvert D; Fort P; Sarda N
Exp Neurol; 2009 Dec; 220(2):341-8. PubMed ID: 19782683
[TBL] [Abstract][Full Text] [Related]
10. Understanding the pathogenesis of Angelman syndrome through animal models.
Jana NR
Neural Plast; 2012; 2012():710943. PubMed ID: 22830052
[TBL] [Abstract][Full Text] [Related]
11. Hypersociability in the Angelman syndrome mouse model.
Stoppel DC; Anderson MP
Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
Low D; Chen KS
Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
[TBL] [Abstract][Full Text] [Related]
13. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
14. Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome.
Hayrapetyan V; Castro S; Sukharnikova T; Yu C; Cao X; Jiang YH; Yin HH
Eur J Neurosci; 2014 Mar; 39(6):1018-1025. PubMed ID: 24329862
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
Gustin RM; Bichell TJ; Bubser M; Daily J; Filonova I; Mrelashvili D; Deutch AY; Colbran RJ; Weeber EJ; Haas KF
Neurobiol Dis; 2010 Sep; 39(3):283-91. PubMed ID: 20423730
[TBL] [Abstract][Full Text] [Related]
16. Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.
Judson MC; Burette AC; Thaxton CL; Pribisko AL; Shen MD; Rumple AM; Del Cid WA; Paniagua B; Styner M; Weinberg RJ; Philpot BD
J Neurosci; 2017 Aug; 37(31):7347-7361. PubMed ID: 28663201
[TBL] [Abstract][Full Text] [Related]
17. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Nociception in Angelman Syndrome Model Mice.
McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
[TBL] [Abstract][Full Text] [Related]
19. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
[TBL] [Abstract][Full Text] [Related]
20. Seizure-like activity in a juvenile Angelman syndrome mouse model is attenuated by reducing Arc expression.
Mandel-Brehm C; Salogiannis J; Dhamne SC; Rotenberg A; Greenberg ME
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5129-34. PubMed ID: 25848016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
